Sources | Names Used |
---|---|
CTRPv2 | salermide:PLX-4032 (12:1 mol/mol) |
PharmacoGx | salermide:PLX-4032 (12:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF717 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
mRNA | ZNF746 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
mRNA | ZNF800 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
mRNA | ZNF816-ZNF321P | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | ZNF823 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
mRNA | ZNF827 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
mRNA | ZNF843 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
mRNA | ZNHIT1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
mRNA | ZSCAN21 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
mRNA | ZXDC | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |